The acceptability and feasibility of a brief psychosocial intervention to reduce bloodborne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual
محفوظ في:
Gilchrist, G., et al., The acceptability and feasibility of a brief psychosocial intervention to reduce bloodborne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual. Harm Reduction Journal, vol. 14, n. 14, 2017, 15 p.
Ref.
523965
الموقع:
SIIS Archivo (R.1830)
Palabras clave:
Drogodependencias, Drogas ilegales, Vía intravenosa, Reducción de daños, Intervención social, Terapia, Modificación de conducta, Evaluación de servicios
Drogodependencias, Drogas ilegales, Vía intravenosa, Reducción de daños, Intervención social, Terapia, Modificación de conducta, Evaluación de servicios
مواد مشابهة: The acceptability and feasibility of a brief psychosocial intervention to reduce bloodborne virus risk behaviours among people who inject drugs: a randomised control feasibility trial of a psychosocial intervention (the PROTECT study) versus treatment as usual
- Feasibility and acceptability of NIDUS-professional, a training and support intervention for homecare workers caring for clients living with dementia: a cluster-randomised feasibility trial
- THE FEASIBILITY AND ACCEPTABILITY OF INTRODUCING BRIEF INTERVENTION FOR ALCOHOL MISUSE IN AN URBAN ABORIGINAL MEDICAL SERVICE
- Feasibility, acceptability, and preliminary efficacy of a positive affect skills intervention for adults with fibromyalgia
- ACCEPTABILITY AND FEASIBILITY OF CLASSROOM-BASED SOCIAL INTERACTION INTERVENTIONS FOR YOUNG CHILDREN WITH DISABILITIES
- Establishing the feasibility and acceptability of a caregiver targeted intervention to improve pain assessment among persons with dementia
- FEASIBILITY AND ACCEPTABILITY OF AN INTRANASAL DIAMORPHINE SPRAY AS AN ALTERNATIVE TO INJECTABLE DIAMORPHINE FOR MAINTENANCE TREATMENT